BIRMINGHAM, Ala.--(BUSINESS WIRE)--New technology leveraging established research, natural compounds, and artificial intelligence is poised to help consumers slow age-related changes in hair and skin. Recent research has demonstrated that changes in our mitochondria—often referred to as the powerhouse of the cell—are at the root of many age-related changes in hair and skin, as well as other systems in our bodies.

阿拉巴马州伯明翰——（商业新闻短讯）——利用已有研究、天然化合物和人工智能的新技术有望帮助消费者减缓与年龄有关的头发和皮肤变化。最近的研究表明，通常被称为细胞动力的线粒体的变化是头发和皮肤以及身体其他系统许多与年龄有关的变化的根源。

Based on this research Yuva Biosciences has utilized AI to comb through thousands of molecules to identify YuvaBio® Y100™ as an ingredient which can help mitigate what scientists refer to as mitochondrial dysfunction. It is now available for licensing to non-drug consumer brands..

基于这项研究，Yuva Biosciences利用人工智能梳理了数千个分子，以确定YuvaBio®Y100™是一种成分，可以帮助减轻科学家所说的线粒体功能障碍。它现在可用于非药物消费品牌的许可。。

“We believe this is one of the biggest innovations in hair loss we’ve seen in twenty-five years” said Dr. Ken Washenik, Chief Medical Officer of Bosley, the industry leader in hair restoration solutions for women and men. BosleyMD® is rolling out its new Revive Plus Densifying Foam with YuvaBio® Y100™ technology for men and women to major national mass retailers, beauty chains, pharmacy chains, and e-commerce sites..

博斯利（Bosley）首席医疗官肯·瓦希尼克（KenWashenik）博士说：“我们相信这是25年来我们在脱发方面看到的最大创新之一。”博斯利是男女头发修复解决方案的行业领导者。BosleyMD®正在向主要的全国性大型零售商、美容连锁店、药店连锁店和电子商务网站推出其新的Revive Plus增密泡沫，该泡沫采用YuvaBio®Y100™技术，适用于男性和女性。。

WORLD LEADER IN MITOCHONDRIAL SCIENCE

线粒体科学的世界领导者

Critical pioneering science in mitochondrial science has been driven by Dr. Keshav K. Singh, Chief Scientific Officer and Co-Founder of Yuva Biosciences. Dr. Singh, a Harvard-trained researcher and Joy and Bill Harbert Endowed Chair and professor at the University of Alabama-Birmingham, is the founding Editor in Chief of the journal Mitochondrion, founder of the Mitochondria Research and Medicine Society and author of more than 100 scientific studies on mitochondria.

Yuva Biosciences首席科学官兼联合创始人Keshav K.Singh博士推动了线粒体科学的关键开创性科学。辛格博士是哈佛大学研究人员，也是阿拉巴马大学伯明翰分校Joy和Bill Harbert捐赠的主席和教授，是《线粒体》杂志的创始主编，线粒体研究与医学协会的创始人，以及100多项线粒体科学研究的作者。

While it was previously known that mitochondrial dysfunction is a key factor involved in overall aging, Dr. Singh was the first to discover and prove experimentally that mitochondrial dysfunction is a key cause of aging for hair and skin and that it can be reversed by restoring mitochondrial function.

虽然先前已知线粒体功能障碍是整体衰老的关键因素，但辛格博士是第一个通过实验发现并证明线粒体功能障碍是头发和皮肤衰老的关键原因，并且可以通过恢复线粒体功能来逆转。

His landmark 2018 study made global headlines and spawned the question: what if products could be made for consumers that help reverse mitochondrial decline and the undesirable changes that follow. In 2019, Yuva Biosciences was born to meet that challenge. Yuva Biosciences experts used AI to identify molecules that could restore mitochondrial function, of which Y100 is the first to market out of the pipeline..

他的里程碑式的2018年研究成为全球头条新闻，并引发了一个问题：如果能为消费者制造产品，帮助扭转线粒体下降和随之而来的不良变化，那该怎么办。2019年，Yuva Biosciences诞生以应对这一挑战。Yuva Biosciences专家使用人工智能来鉴定可以恢复线粒体功能的分子，其中Y100是第一个上市的。。

EXPERIENCE IN TRANSLATING SCIENCE INTO PRODUCTS

将科学转化为产品的经验

The Yuva Biosciences team also has considerable experience in translating science into products, including the CEO, Greg Schmergel, who is a serial entrepreneur whose previous company was in the nanotechnology field, and well-known consumer products innovation leader Dr. Shekhar Mitra. Dr. Mitra was previously the Senior Vice President of Corporate Innovation at Procter & Gamble and part of P&G’s Global Leadership Council.

Yuva Biosciences团队在将科学转化为产品方面也有丰富的经验，包括首席执行官格雷格·施梅格尔（Greg Schmergel），他是一位连续创业者，之前的公司是纳米技术领域的，以及著名的消费品创新领导者谢哈尔·米特拉博士。Mitra博士曾任宝洁公司企业创新高级副总裁，也是宝洁全球领导委员会成员。

Under his leadership, P&G created and developed many successful globally-renowned products, such as Oil of Olay Regenerist, Crest Whitestrips, Crest ProHealth, Aleve Analgesic, Prilosec, Old Spice Clinical Strength, and many others. Dr. Mitra has been awarded over 50 patents, and notes that, “Applying a unique platform based on mitochondrial science to create breakthrough products for skin care and hair care, as Yuva Biosciences has done, is a real game-changer, with noticeable effects being seen already in multiple clinical trials and now in products on the shelves.”.

在他的领导下，宝洁创造并开发了许多成功的全球知名产品，如玉兰油Regenerist、佳洁士Whitestrips、佳洁士ProHealth、Aleve镇痛药、Prilosec、Old Spice Clinical Strength等。Mitra博士获得了50多项专利，并指出，“正如Yuva Biosciences所做的那样，应用基于线粒体科学的独特平台来创造突破性的皮肤护理和头发护理产品，是一个真正的游戏规则改变者，已经在多项临床试验中看到了明显的效果，现在已经在货架上的产品中看到了。”。

INVESTOR EXCITEMENT

投资者的兴奋

In related news, VentureSouth, one of the country’s largest angel investment networks, announced that it led a $7.5M seed round for Yuva Biosciences. 'Tens of billions of dollars are spent every year on cosmetics products that address symptoms of aging but don't actually slow the aging process,” said Matt Dunbar, Managing Director at VentureSouth.

在相关新闻中，该国最大的天使投资网络之一VentureSouth宣布，它领导了Yuva Biosciences一轮750万美元的种子投资VentureSouth董事总经理马特·邓巴（MattDunbar）表示：“每年有数百亿美元用于化妆品，这些化妆品可以缓解衰老症状，但实际上并不能减缓衰老过程。”。

'Yuva Biosciences' technology solves this problem with once-in-a-generation innovation by fighting a key root cause of aging, mitochondrial dysfunction. We are truly excited about the potential impact these products can have for millions of consumers,' he concluded. VentureSouth has invested over $82 million in more than 100 companies.

“Yuva Biosciences”技术通过与衰老的关键根源线粒体功能障碍作斗争，通过一代创新一次解决了这个问题。他总结道，我们对这些产品可能对数百万消费者产生的潜在影响感到非常兴奋。VentureSouth已向100多家公司投资8200多万美元。

More information is available at https://venturesouth.vc/. Other investors in the round include Longevity Tech Fund (https://www.longevitytech.fund/), TBD Angels (https://tbdangels.com/) and Atma Capital (https://atmacap.com). The team is comprised of alumni from MIT, McKinsey, along with a distinguished board of tech titans, global C-Level executives, and founders in every major deep tech vertical..

有关更多信息，请访问https://venturesouth.vc/.本轮投资的其他投资者包括长寿科技基金(https://www.longevitytech.fund/)，待定天使(https://tbdangels.com/)和Atma Capital(https://atmacap.com)。该团队由麻省理工学院（MIT）、麦肯锡（McKinsey）的校友以及杰出的科技巨头董事会、全球C级高管和各大深度科技垂直领域的创始人组成。。

WHAT’S NEXT

下一步是什么

‘With the world’s first and only proven platform to search specifically for new compounds that improve mitochondrial health, Yuva Biosciences is starting with hair and skin aging, with the potential to address other mitochondrial-related issues such as ovarian aging (fertility and menopausal issues), wound care and more,” said Yuva Bioscience’s CEO and Co-founder Greg Schmergel.

Yuva Biosciences首席执行官兼联合创始人格雷格·施梅格尔（Greg Schmergel）说：“Yuva Biosciences是世界上第一个也是唯一一个专门寻找改善线粒体健康的新化合物的经验证的平台，它正在从头发和皮肤衰老开始，并有可能解决其他与线粒体相关的问题，如卵巢衰老（生育和更年期问题），伤口护理等。”。

Schmergel has started multiple companies previously, raising over $140M collectively, and has served on the boards of start-ups, hospitals, and organizations supporting entrepreneurship..

施梅格尔之前创办了多家公司，共筹集了1.4亿美元，并曾在初创企业、医院和支持创业的组织的董事会任职。。

About Yuva Biosciences (www.yuvabio.com). Yuva Biosciences is a longevity company harnessing the cutting edge of mitochondrial science to help consumer brands develop products targeted at aging-related hair loss, wrinkled skin, and many other symptoms of aging. Yuva Biosciences is headquartered in Birmingham, Alabama..

关于Yuva Biosciences（www.yuvabio.com）。Yuva Biosciences是一家长寿公司，利用线粒体科学的前沿技术，帮助消费者品牌开发针对衰老相关的脱发，皱纹皮肤和许多其他衰老症状的产品。尤瓦生物科学公司总部位于阿拉巴马州伯明翰。。